A detailed history of Zwj Investment Counsel Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Zwj Investment Counsel Inc holds 6,379 shares of LLY stock, worth $5.03 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
6,379
Previous 6,375 0.06%
Holding current value
$5.03 Million
Previous $5.77 Million 2.08%
% of portfolio
0.24%
Previous 0.26%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $3,088 - $3,840
4 Added 0.06%
6,379 $5.65 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $21,746 - $27,271
30 Added 0.47%
6,375 $5.77 Million
Q1 2024

Apr 26, 2024

BUY
$592.2 - $792.28 $103,042 - $137,856
174 Added 2.82%
6,345 $4.94 Million
Q4 2023

Jan 31, 2024

SELL
$525.19 - $619.13 $25,734 - $30,337
-49 Reduced 0.79%
6,171 $3.6 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $70,421 - $97,086
162 Added 2.67%
6,220 $3.34 Million
Q2 2023

Jul 13, 2023

SELL
$350.74 - $468.98 $52,611 - $70,347
-150 Reduced 2.42%
6,058 $2.84 Million
Q1 2023

Apr 26, 2023

BUY
$310.63 - $364.82 $21,122 - $24,807
68 Added 1.11%
6,208 $2.13 Million
Q3 2022

Oct 19, 2022

SELL
$296.48 - $337.87 $1,778 - $2,027
-6 Reduced 0.1%
6,140 $1.99 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $125,707 - $147,598
451 Added 7.92%
6,146 $1.99 Million
Q3 2021

Mar 31, 2022

BUY
$221.6 - $272.71 $33,240 - $40,906
150 Added 2.71%
5,695 $1.32 Million
Q2 2021

Mar 31, 2022

SELL
$180.55 - $233.54 $59,039 - $76,367
-327 Reduced 5.57%
5,545 $1.27 Million
Q1 2021

May 06, 2021

SELL
$164.32 - $212.72 $6,244 - $8,083
-38 Reduced 0.64%
5,872 $1.1 Million
Q4 2020

Feb 26, 2021

BUY
$130.46 - $172.63 $13,698 - $18,126
105 Added 1.81%
5,910 $998,000
Q3 2020

Nov 03, 2020

SELL
$146.22 - $169.13 $15,353 - $17,758
-105 Reduced 1.78%
5,805 $859,000
Q2 2020

Jul 28, 2020

SELL
$136.42 - $164.18 $5,866 - $7,059
-43 Reduced 0.72%
5,910 $970,000
Q1 2020

May 18, 2020

BUY
$119.05 - $147.35 $43,453 - $53,782
365 Added 6.53%
5,953 $826,000
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $33,465 - $41,450
313 Added 5.93%
5,588 $734,000
Q1 2019

May 21, 2019

SELL
$111.31 - $131.02 $667 - $786
-6 Reduced 0.11%
5,275 $684,000
Q4 2018

Feb 08, 2019

BUY
$105.9 - $118.64 $635 - $711
6 Added 0.11%
5,281 $611,000
Q1 2018

Apr 24, 2018

SELL
$74.21 - $87.6 $48,162 - $56,852
-649 Reduced 10.96%
5,275 $408,000
Q4 2017

Feb 01, 2018

BUY
$81.94 - $87.89 $1,229 - $1,318
15 Added 0.25%
5,924 $500,000
Q3 2017

Nov 03, 2017

BUY
$77.07 - $85.54 $455,406 - $505,455
5,909
5,909 $505,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Zwj Investment Counsel Inc Portfolio

Follow Zwj Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zwj Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Zwj Investment Counsel Inc with notifications on news.